Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuan Huang Fang is a Traditional Chinese Medicine (TCM) herbal formula developed primarily by the Shanghai Municipal Hospital of Traditional Chinese Medicine for the treatment and prevention of various renal conditions. It is frequently studied for its nephroprotective effects, particularly in mitigating cisplatin-induced renal impairment and managing chronic kidney disease (CKD), acute-on-chronic kidney injury, and IgA nephropathy. The formula is often used as an adjuvant therapy alongside standard treatments like valsartan or glutathione to improve renal function and reduce inflammation. Clinical trials have explored its efficacy in preventing chemotherapy-induced nephrotoxicity in patients with lung, gastric, and colorectal cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chuan Huang Fang.